课题基金 / 基金详情

FUNCTIONS OF PREGNANCY SPECIFIC GLYCOPROTEINS

FUNCTIONS OF PREGNANCY SPECIFIC GLYCOPROTEINS
妊娠特异性糖蛋白的功能
批准号：
2889427
负责人：
Gabriela S Dveksler
金额：
$10.35万
依托单位：
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-07-01 至 2003-06-30
来源：
https://reporter.nih.gov/project-details/2889427
关键词：
RNase protection assay SDS polyacrylamide gel electrophoresis affinity labeling animal tissue antibody formation complementary DNA cytokine enzyme linked immunosorbent assay glycoproteins human tissue immunoglobulin genes immunomodulators in situ hybridization laboratory mouse macrophage molecular cloning nucleic acid probes placenta polymerase chain reaction pregnancy pregnancy disorder pregnancy immunology protein biosynthesis protein structure function receptor binding

项目摘要

项目成果

Gabriela S Dveksler的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pregnancy specific glycoproteins (PSGs) are a family of secreted proteins produced by the placenta. These proteins belong to the immunoglobulin gene super family and are essential for a successful pregnancy. Expression of PSGs has been observed in many species including humans and mice. Our long-range goal is to define the roles and mechanisms of action of pregnancy specific glycoproteins in normal and abnormal pregnancy. The objective of this application is to characterize the initial interaction of PSGs with receptor-bearing target cells to clone their receptor, to clone their receptor, and to evaluate their ability to regulate the production of cytokines and other mediators of inflammation. The central hypothesis of the application is that PSGs bind to a specific cellular receptor on target cells and that this interaction contributes to the regulation of immune and inflammatory mediators which are essential for a normal pregnancy outcome. The rationale behind the proposed research is that PSGs are involved, through binding to a specific cellular receptor on mononuclear phagocytes in modulating mediators of the immune response, such as IL-10, thereby preventing the feto-placental damage that could ensue from local inflammation. The future development of therapeutic interventions, aimed at manipulation of immunomodu-latory effects of PSGs during pregnancy, will depend on careful definition of specific PSG functions. To accomplish the objectives of this application, we will pursue two specific aims: (1) Clone and characterize the cDNA encoding the cellular receptor for murine PSGs on murine macrophages; (2) Characterize the roles of murine PSG2, PSG3, and PSG4 and human PSG6 as immunomodulators in vitro. We expect that the results obtained will aid in the definition of the roles of this glycoprotein family in maintaining normal pregnancy and that this knowledge will result in the development of new therapeutic strategies related to the management of complicated pregnancies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Not all members of the pregnancy-specific glycoprotein family are created equal
Not all members of the pregnancy-specific glycoprotein family are created equal
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System